AMNEAL PHARMACEUTICALS INC. 2023-2024 Proxy Voting Records

Description as filed by funds: Election of Directors: Chintu Patel

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Chintu Patel”): 254,283,523 for, 1,100,436 against, per its Form 8-K filed May 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 33,504,603 for, 17 against.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of Directors: Chirag Patel

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Chirag Patel”): 254,065,112 for, 1,379,383 against, per its Form 8-K filed May 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 33,221,430 for, 283,190 against.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of Directors: Deb Autor

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Deb Autor”): 254,054,265 for, 1,609,738 against, per its Form 8-K filed May 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 33,282,953 for, 221,667 against.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of Directors: Emily Peterson Alva

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Emily Peterson Alva”): 253,927,467 for, 1,736,375 against, per its Form 8-K filed May 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 33,282,953 for, 221,667 against.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of Directors: Gautam Patel

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Gautam Patel”): 251,712,874 for, 3,732,183 against, per its Form 8-K filed May 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 33,117,624 for, 386,996 against.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of Directors: J. Kevin Buchi

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: J. Kevin Buchi”): 253,532,508 for, 2,069,308 against, per its Form 8-K filed May 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 33,282,938 for, 221,682 against.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of Directors: Jeff George

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jeff George”): 253,898,828 for, 1,763,854 against, per its Form 8-K filed May 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 33,282,953 for, 221,667 against.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of Directors: John Kiely

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: John Kiely”): 253,584,848 for, 2,015,861 against, per its Form 8-K filed May 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 33,282,938 for, 221,682 against.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of Directors: Paul Meister

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Paul Meister”): 238,720,752 for, 16,941,409 against, per its Form 8-K filed May 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 27,850,163 for, 5,654,457 against.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of Directors: Shlomo Yanai

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Shlomo Yanai”): 254,374,881 for, 1,067,043 against, per its Form 8-K filed May 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 33,504,603 for, 17 against.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Election of Directors: Ted Nark

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Ted Nark”): 253,943,612 for, 1,499,704 against, per its Form 8-K filed May 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successo…”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 33,504,588 for, 32 against.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: Advisory vote to approve executive compensation.

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“2. To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers”): 254,365,134 for, 1,199,935 against, per its Form 8-K filed May 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 65 managers: 33,504,620 for. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 139 managers: 50,845,922 for, 209,671 against. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal 2024.

AMNEAL PHARMACEUTICALS INC.’s own tally for this item (“3. To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 279,106,284 for, 624,760 against, per its Form 8-K filed May 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 33,504,588 for, 32 against.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.